Cargando...
Drug repurposing and cytokine management in response to COVID-19: A review
Coronavirus disease 2019 (COVID-19), the infectious disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is an aggressive disease that attacks the respiratory tract and has a higher fatality rate than seasonal influenza. The COVID‐19 pandemic is a global health crisis,...
Guardado en:
| Publicado en: | Int Immunopharmacol |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7457938/ https://ncbi.nlm.nih.gov/pubmed/32919216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.intimp.2020.106947 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|